About Infectious Disease and the Elderly

Young children and the elderly are the most susceptible age groups to various infectious diseases and are much less able to respond to preventive measures such as vaccination and immunotherapy, the reasons for which are unknown.


The problem is serious and world-wide, growing as the elderly population grows. The need for better protection for the elderly is becoming a global concern.

U of S Research Strengths in Infectious Disease and the Elderly

The U of S has internationally recognized researchers and outstanding infrastructure in infectious disease and vaccine research and research in life sciences is a priority of the U of S. Below are just some of the supports that are available to U of S our researchers:


  • In 2007 the University established a School of Public Health which promotes community-involved, multidisciplinary activities targeted at enhancing all health-related research on campus and include a significant emphasis on infectious diseases and immunology.
  • The University’s research cluster is extensive, including the Vaccine and Infectious Disease Organization (VIDO/InterVac), a recognized global leader in the field of vaccine development and is an autonomous research entity of the University. InterVac, currently under construction, will be the largest facility for vaccinology and immunotherapeutics in the world, and will provide strong competitive advantages for the University as a site for advanced research on vaccine technologies. More »